Immunoglobulin (Ig)/BCL6 versus non-Ig/BCL6 gene fusion in diffuse large B-cell lymphoma corresponds to a high-versus low-level expression of BCL6 mRNA

被引：24
|
作者：
Ueda, C [1 ]
Uchiyama, T [1 ]
Ohno, H [1 ]
机构：
[1] Kyoto Univ, Fac Med, Dept Internal Med, Sakyo Ku, Kyoto 6068507, Japan
来源：
BLOOD | 2002年 / 99卷 / 07期
关键词：
D O I：
10.1182/blood-2001-11-0117
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2624 / 2625
页数：2
相关论文
共 50 条
  • [21] MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
    Horn, Heike
    Ziepert, Marita
    Becher, Claudia
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Feller, Alfred C.
    Klapper, Wolfram
    Hummel, Michael
    Stein, Harald
    Hansmann, Martin-Leo
    Schmelter, Christopher
    Moeller, Peter
    Cogliatti, Sergio
    Pfreundschuh, Michael
    Schmitz, Norbert
    Truemper, Lorenz
    Siebert, Reiner
    Loeffler, Markus
    Rosenwald, Andreas
    Ott, German
    BLOOD, 2013, 121 (12) : 2253 - 2263
  • [22] A mouse model of diffuse large B-cell lymphoma induced by deregulated BCL6 expression.
    Cattoretti, G
    Pasqualucci, L
    Ballon, G
    Tam, W
    Murty, VV
    Morse, HC
    Dalla-Favera, R
    BLOOD, 2003, 102 (11) : 136A - 136A
  • [23] REARRANGEMENTS OF THE BCL6 GENE IN DIFFUSE LARGE-CELL NON-HODGKINS-LYMPHOMA
    LOCOCO, F
    YE, BH
    LISTA, F
    CORRADINI, P
    OFFIT, K
    KNOWLES, DM
    CHAGANTI, RSK
    DALLAFAVERA, R
    BLOOD, 1994, 83 (07) : 1757 - 1759
  • [24] Therapeutic targeting of the BCL6 oncogene in diffuse large B-cell lymphomas
    Melnick, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 97 - 97
  • [25] Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas
    Parekh, Samir
    Prive, Gilbert
    Melnick, Ari
    LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 874 - 882
  • [26] A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma
    Saito, Masumichi
    Gao, Jie
    Basso, Katia
    Kitagawa, Yukiko
    Smith, Paula M.
    Bhagat, Govind
    Pernis, Alessandra
    Pasqualucci, Laura
    Dalla-Favera, Riccardo
    CANCER CELL, 2007, 12 (03) : 280 - 292
  • [27] Mediastinal B-cell lymphoma with MYC, BCL2, and BCL6 rearrangements
    Ocal, Jon L.
    Feldman, Andrew L.
    Greipp, Patricia T.
    Rimsza, Lisa M.
    JOURNAL OF HEMATOPATHOLOGY, 2022, 15 (03) : 151 - 155
  • [28] ARSENIC TRIOXIDE TARGETS BCL6 FOR DEGRADATION AND INHIBITS THE PROLIFERATION OF BCL6-DEPENDENT DIFFUSE LARGE B-CELL LYMPHOMA
    Tse, E.
    Yue, K.
    Chau, D.
    Kwong, Y. -L.
    HAEMATOLOGICA, 2017, 102 : 571 - 571
  • [29] BCL6 gene rearrangement and other cytogenetic abnormalities in diffuse large cell lymphoma
    Offit, K
    Louie, DC
    Parsa, NZ
    Roy, P
    Leung, D
    LoCoco, F
    Zelenetz, A
    DallaFavera, R
    Chaganti, RSK
    LEUKEMIA & LYMPHOMA, 1995, 20 (1-2) : 85 - 89
  • [30] BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)
    Akyurek, N.
    Uner, A.
    Benekli, M.
    Barista, I.
    LABORATORY INVESTIGATION, 2010, 90 : 283A - 283A
12345